ImportRefusal LogoImportRefusal

GENBODY INC

⚠️ High Risk

FEI: 3014660585 • Cheonan, Chungnam • SOUTH KOREA

FEI

FEI Number

3014660585

📍

Location

Cheonan, Chungnam

🇰🇷
🏢

Address

3-18 Eopseong 2- Gil,, Seobuk-gu,, Cheonan, Chungnam, South Korea

High Risk

FDA Import Risk Assessment

57.9
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

18
Total Refusals
5
Unique Violations
5/1/2024
Latest Refusal
7/24/2017
Earliest Refusal

Score Breakdown

Violation Severity
69.5×40%
Refusal Volume
47.4×30%
Recency
66.1×20%
Frequency
26.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

50814×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

713×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

24801×

RXPERSONAL

The article appears to be a device which requires a prescription from your doctor.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

38731×

708NOREG

It has been determined the drug was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
5/1/2024
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of West Coast Imports (DWCI)
6/3/2021
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
508NO 510(K)
Division of Southeast Imports (DSEI)
2/16/2021
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
3873708NOREG
Division of West Coast Imports (DWCI)
2/16/2021
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of Southeast Imports (DSEI)
1/21/2021
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of West Coast Imports (DWCI)
12/21/2020
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of West Coast Imports (DWCI)
12/1/2020
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
508NO 510(K)
Division of Southeast Imports (DSEI)
10/20/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
508NO 510(K)
Division of Southeast Imports (DSEI)
10/1/2020
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of Southeast Imports (DSEI)
9/4/2020
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of West Coast Imports (DWCI)
8/17/2020
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of Northern Border Imports (DNBI)
7/24/2020
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of Northern Border Imports (DNBI)
7/24/2020
83QKOREAGENT, CORONAVIRUS SEROLOGICAL
508NO 510(K)
Division of Northern Border Imports (DNBI)
7/20/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
2480RXPERSONAL
508NO 510(K)
Division of Southeast Imports (DSEI)
5/27/2020
83QKPCORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
336INCONSPICU
508NO 510(K)
Division of Southeast Imports (DSEI)
7/24/2017
57UH28IMMUNE GLOBULIN
71NO LICENSE
Division of Southeast Imports (DSEI)
7/24/2017
57UH28IMMUNE GLOBULIN
71NO LICENSE
Division of Southeast Imports (DSEI)
7/24/2017
57UH28IMMUNE GLOBULIN
71NO LICENSE
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is GENBODY INC's FDA import refusal history?

GENBODY INC (FEI: 3014660585) has 18 FDA import refusal record(s) in our database, spanning from 7/24/2017 to 5/1/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GENBODY INC's FEI number is 3014660585.

What types of violations has GENBODY INC received?

GENBODY INC has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about GENBODY INC come from?

All FDA import refusal data for GENBODY INC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.